Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
The following terms were ignored: [, ]
Page 1
[Reasons for delayed and discontinued therapy in age-related macular degeneration].
Wintergerst MWM, Bouws J, Loss J, Heimes B, Pauleikhoff D, Holz FG, Finger RP. Wintergerst MWM, et al. Ophthalmologe. 2018 Dec;115(12):1035-1041. doi: 10.1007/s00347-017-0610-z. Ophthalmologe. 2018. PMID: 29138977 German.
BACKGROUND: Critical prerequisites for successful therapy of neovascular age-related macular degeneration (nvAMD) are an early initiation and continuous monitoring; however, delays in starting therapy and non-medically indicated …
BACKGROUND: Critical prerequisites for successful therapy of neovascular age-related macular degeneration …
Lost to follow-up while undergoing intravitreal injection therapy: barriers to adherence in a real-world setting.
Licht A, Mavris Y, Latz C, Schuster AK, Ponto KA, Mirshahi A. Licht A, et al. Int J Retina Vitreous. 2026 Feb 11;12(1):39. doi: 10.1186/s40942-026-00808-3. Int J Retina Vitreous. 2026. PMID: 41673898 Free PMC article.
BACKGROUND: Intravitreal anti-VEGF therapy is effective, yet real-world outcomes are limited by non persistence. We investigated patient-reported reasons for discontinuation under pro-re-nata therapy protocol. METHODS: This ambispective real-world stud …
BACKGROUND: Intravitreal anti-VEGF therapy is effective, yet real-world outcomes are limited by non persistence. We investigated pati …